- Home
- FCT vs SOPH Comparison
FCT vs SOPH Comparison
Compare FCT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCT
- SOPH
- Stock Information
- Founded
- FCT 2004
- SOPH 2011
- Country
- FCT United States
- SOPH Switzerland
- Employees
- FCT N/A
- SOPH N/A
- Industry
- FCT Finance Companies
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FCT Finance
- SOPH Health Care
- Exchange
- FCT Nasdaq
- SOPH Nasdaq
- Market Cap
- FCT 266.8M
- SOPH 226.6M
- IPO Year
- FCT N/A
- SOPH 2021
- Fundamental
- Price
- FCT $10.28
- SOPH $3.26
- Analyst Decision
- FCT
- SOPH Strong Buy
- Analyst Count
- FCT 0
- SOPH 3
- Target Price
- FCT N/A
- SOPH $7.00
- AVG Volume (30 Days)
- FCT 106.8K
- SOPH 21.3K
- Earning Date
- FCT 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- FCT 11.29%
- SOPH N/A
- EPS Growth
- FCT N/A
- SOPH N/A
- EPS
- FCT N/A
- SOPH N/A
- Revenue
- FCT N/A
- SOPH $64,488,000.00
- Revenue This Year
- FCT N/A
- SOPH $7.20
- Revenue Next Year
- FCT N/A
- SOPH $15.71
- P/E Ratio
- FCT N/A
- SOPH N/A
- Revenue Growth
- FCT N/A
- SOPH 9.85
- 52 Week Low
- FCT $9.45
- SOPH $2.70
- 52 Week High
- FCT $10.42
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- FCT 45.38
- SOPH 46.64
- Support Level
- FCT $10.25
- SOPH $3.06
- Resistance Level
- FCT $10.44
- SOPH $3.47
- Average True Range (ATR)
- FCT 0.09
- SOPH 0.18
- MACD
- FCT -0.01
- SOPH -0.00
- Stochastic Oscillator
- FCT 21.81
- SOPH 45.45
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is the United States based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, the fund attempts to preserve capital. The fund seeks to achieve the objectives by investing in a portfolio of senior floating-rate loan interests. Its portfolio of investments consists of aerospace and defense, agricultural products, broadcasting, cable and satellite, electric utilities and other sectors.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.